June 1, 2026 Osisko Development Announces Closings of Additional US$75 Million Aggregate Principal Amount of 4.125% Convertible Senior Notes Bringing Total Offering to US$300 Million
June 1, 2026 Iterion Therapeutics Reports First Clinical Validation of Tegavivint as a Targeted Therapy for Wnt-Driven Advanced HCC in Oral Presentation at 2026 ASCO Annual Meeting
June 1, 2026 Fasoo AI and Konsilix Complete Formation of Symbologic, Inc., Delivering Secure Operational Intelligence for the Enterprise
